- NEWS
Prion diseases are caused by misfolded proteins, but a new tool can stop them forming in mice.
A molecular-editing tool that’s small enough to be delivered to the brain shuts down the production of proteins that cause prion diseases, a rare but deadly group of neurodegenerative disorders.
Access options
Access through your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 52 print issues and online access
$199.00 per year
only $3.83 per issue
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-024-02115-z
References
Neumann, E. N. et al. Science 384, eado7082 (2024).
Raymond, G. J. et al. JCI Insight 5, e131175 (2019).
Nuñez, J. K. et al. Cell 184, 2503–2519 (2021).
Related Articles
Subjects
Latest on:
Jobs
-
Postdoctoral Associate / Research Scientist in Systems Neuroscience and/or Neuroengineering
Elucidating the role of dopamine and the basal ganglia in learning, decision making, and motor control in health and disease with advanced neurotech.
University of Pittsburgh, Pittsburgh
University of Pittsburgh - Center for the Neural Basis of Cognition / Bioengineering
-
Prospective Independent Research Group Leaders (m/f/d)
Biology (FAU) seeks outstanding early-career researchers to establish externally funded independent groups in a highly collaborative environment.
Erlangen, Bayern (DE)
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
-
Talent Recruitment Announcement at the College of Plant Science & Technology
Gather Global Talents, Forge Great Achievements
Wuhan, Hubei (CN)
Huazhong Agricultural University (HZAU)
-
Recruitment Announcement for High-Level Talent at the Center for Agricultural Microbiology
Join HZAU's global faculty team to advance research with competitive benefits.
Wuhan, Hubei (CN)
Huazhong Agricultural University (HZAU)
-
Group Leader - Neural Circuit Regulation of Immune Function
The BioMed X Institute in New Haven, USA is establishing a new Build-to-Solve research group, fully funded by Biogen.
New Haven, Connecticut, USA
BioMed X Germany GmbH
‘Epigenetic’ editing cuts cholesterol in mice
Can epigenetics help verify the age claims of refugees?
Epigenetics: The sins of the father
Epigenetics: Beyond face value